Discover Top 10 Pharma Companies in India : Sun Pharma, Dr. Reddy’s, Cipla, Lupin, Aurobindo, Cadila, Torrent, Biocon, Glenmark, Divi’s, and Wockhardt. Leading in generics, biotechnology, and APIs, these companies drive global healthcare innovation with extensive operations in key markets like India, USA, and Europe. With substantial revenues and diverse product portfolios, they play crucial roles in advancing healthcare accessibility and innovation globally, underpinned by significant market capitalizations reflecting their strategic importance and growth potential.Discover India’s top pharmaceutical giants: Sun Pharma, Dr. Reddy’s, Cipla, Lupin, Aurobindo, Cadila, Torrent, Biocon, Glenmark, Divi’s, and Wockhardt. Leading in generics, biotechnology, and APIs, these companies drive global healthcare innovation with extensive operations in key markets like India, USA, and Europe. With substantial revenues and diverse product portfolios, they play crucial roles in advancing healthcare accessibility and innovation globally, underpinned by significant market capitalizations reflecting their strategic importance and growth potential.
Table of Contents
1. Dr. Reddy’s Laboratories Ltd.
Dr. Reddy’s Laboratories Ltd., founded in 1984 and headquartered in Hyderabad, Telangana, India, is a prominent pharmaceutical company specializing in generics, active pharmaceutical ingredients (APIs), and proprietary products. Co-chaired by G.V. Prasad, the company operates globally with a strong presence in India, USA, Europe, and Emerging Markets. As of FY 2022, Dr. Reddy’s reported revenues of approximately ₹ 21,393 crore ($2.9 billion) and employs over 21,000 people worldwide. The company’s market capitalization stands at around ₹ 97,208 crore ($13 billion).
| Company Name | Dr. Reddy’s Laboratories Ltd. |
|---|---|
| Founded | 1984 |
| Headquarters | Hyderabad, Telangana, India |
| Key People | G.V. Prasad (Co-Chairman & MD) |
| Products | Pharmaceuticals, generic drugs, APIs |
| Revenue (FY 2022) | ₹ 21,393 crore (approx. $2.9 billion) |
| Number of Employees | Over 21,000 |
| Market Cap (2022) | ₹ 97,208 crore (approx. $13 billion) |
| Key Markets | India, USA, Europe, Emerging Markets |
| Key Subsidiaries | Dr. Reddy’s Laboratories, Inc., Biologics |
| Website | Dr. Reddy’s Laboratories Ltd. |
Also Read : Top 10 hospitals in India
2. Cipla Ltd.
Cipla Ltd., established in 1935 and based in Mumbai, Maharashtra, India, is a leading global pharmaceutical company focusing on generics, biotechnology, and healthcare products. Led by Umang Vohra as MD & Global CEO, Cipla operates extensively across India, USA, South Africa, and other Emerging Markets. In FY 2022, Cipla reported revenues of approximately ₹ 23,719 crore ($3.2 billion) and employs over 30,000 people worldwide. The company’s market capitalization as of 2022 is around ₹ 78,369 crore ($10.5 billion).
| Company Name | Cipla Ltd. |
|---|---|
| Founded | 1935 |
| Headquarters | Mumbai, Maharashtra, India |
| Key People | Umang Vohra (MD & Global CEO) |
| Products | Pharmaceuticals, biotechnology |
| Revenue (FY 2022) | ₹ 23,719 crore (approx. $3.2 billion) |
| Number of Employees | Over 30,000 |
| Market Cap (2022) | ₹ 78,369 crore (approx. $10.5 billion) |
| Key Markets | India, USA, South Africa, Emerging Markets |
| Key Subsidiaries | Cipla BioTec, Cipla USA |
| Website | Cipla Ltd. |
3. Lupin Ltd.
Lupin Ltd., established in 1968 and headquartered in Mumbai, Maharashtra, India, is a global pharmaceutical company known for its focus on generics, biosimilars, and specialty pharmaceuticals. Vinita Gupta leads the company as CEO. Lupin operates extensively in India, USA, Europe, and Asia-Pacific markets. In FY 2022, Lupin reported revenues of approximately ₹ 18,934 crore ($2.5 billion) with a workforce of over 17,000 employees globally. The company’s market capitalization stands at around ₹ 46,835 crore ($6.3 billion) as of 2022.
| Company Name | Lupin Ltd. |
|---|---|
| Founded | 1968 |
| Headquarters | Mumbai, Maharashtra, India |
| Key People | Vinita Gupta (CEO) |
| Products | Pharmaceuticals, generics, biosimilars |
| Revenue (FY 2022) | ₹ 18,934 crore (approx. $2.5 billion) |
| Number of Employees | Over 17,000 |
| Market Cap (2022) | ₹ 46,835 crore (approx. $6.3 billion) |
| Key Markets | India, USA, Europe, Asia-Pacific |
| Key Subsidiaries | Kyowa Pharmaceutical Industry Co. Ltd. |
| Website | Lupin Ltd. |
4. Aurobindo Pharma Ltd.
Aurobindo Pharma Ltd., founded in 1986 and headquartered in Hyderabad, Telangana, India, is a major pharmaceutical company specializing in APIs, generics, and formulations. N. Govindarajan serves as Managing Director. Aurobindo Pharma has a strong presence in key markets such as USA, Europe, and Emerging Markets. In FY 2022, the company reported revenues of approximately ₹ 25,925 crore ($3.5 billion) with over 20,000 employees globally. Aurobindo Pharma’s market capitalization as of 2022 is approximately ₹ 54,667 crore ($7.3 billion).
| Company Name | Aurobindo Pharma Ltd. |
|---|---|
| Founded | 1986 |
| Headquarters | Hyderabad, Telangana, India |
| Key People | N. Govindarajan (MD) |
| Products | Pharmaceuticals, APIs, generics |
| Revenue (FY 2022) | ₹ 25,925 crore (approx. $3.5 billion) |
| Number of Employees | Over 20,000 |
| Market Cap (2022) | ₹ 54,667 crore (approx. $7.3 billion) |
| Key Markets | USA, Europe, Emerging Markets |
| Key Subsidiaries | AuroMedics Pharma LLC, Eugia Pharma |
| Website | Aurobindo Pharma Ltd. |
5. Cadila Healthcare Ltd.
Cadila Healthcare Ltd., established in 1952 and based in Ahmedabad, Gujarat, India, is a prominent pharmaceutical company specializing in pharmaceuticals and biotechnology. Pankaj R. Patel serves as Chairman of the company. Cadila Healthcare operates widely across India, USA, and Emerging Markets. In FY 2022, the company reported revenues of approximately ₹ 18,341 crore ($2.5 billion) with a workforce of over 25,000 employees globally. The company’s market capitalization stands at around ₹ 47,523 crore ($6.4 billion) as of 2022.
| Company Name | Cadila Healthcare Ltd. |
|---|---|
| Founded | 1952 |
| Headquarters | Ahmedabad, Gujarat, India |
| Key People | Pankaj R. Patel (Chairman) |
| Products | Pharmaceuticals, biotechnology |
| Revenue (FY 2022) | ₹ 18,341 crore (approx. $2.5 billion) |
| Number of Employees | Over 25,000 |
| Market Cap (2022) | ₹ 47,523 crore (approx. $6.4 billion) |
| Key Markets | India, USA, Emerging Markets |
| Key Subsidiaries | Zydus Animal Health, Biochem Pharmaceuticals |
| Website | Cadila Healthcare Ltd. |
6. Torrent Pharmaceuticals Ltd.
Torrent Pharmaceuticals Ltd., founded in 1959 and headquartered in Ahmedabad, Gujarat, India, is a leading pharmaceutical company specializing in generics, formulations, and active pharmaceutical ingredients (APIs). Samir Mehta serves as Chairman. Torrent Pharma operates across key markets including India, USA, Brazil, and Rest of World. In FY 2022, the company reported revenues of approximately ₹ 10,688 crore ($1.4 billion) with over 13,000 employees globally. The company’s market capitalization stands at around ₹ 32,845 crore ($4.4 billion) as of 2022.
| Company Name | Torrent Pharmaceuticals Ltd. |
|---|---|
| Founded | 1959 |
| Headquarters | Ahmedabad, Gujarat, India |
| Key People | Samir Mehta (Chairman) |
| Products | Pharmaceuticals, generics, APIs |
| Revenue (FY 2022) | ₹ 10,688 crore (approx. $1.4 billion) |
| Number of Employees | Over 13,000 |
| Market Cap (2022) | ₹ 32,845 crore (approx. $4.4 billion) |
| Key Markets | India, USA, Brazil, Rest of World |
| Key Subsidiaries | Heumann Pharma, Zeneus Pharma |
| Website | Torrent Pharmaceuticals Ltd. |
7. Biocon Ltd.
Biocon Ltd., founded in 1978 and headquartered in Bangalore, Karnataka, India, is a leading biopharmaceutical company focusing on APIs, generics, and biologics. Kiran Mazumdar-Shaw serves as the Executive Chairperson. Biocon operates across India, USA, Europe, and Emerging Markets. In FY 2022, the company reported revenues of approximately ₹ 7,091 crore ($950 million) with over 12,000 employees globally. Biocon’s market capitalization as of 2022 is approximately ₹ 37,718 crore ($5 billion).
| Company Name | Biocon Ltd. |
|---|---|
| Founded | 1978 |
| Headquarters | Bangalore, Karnataka, India |
| Key People | Kiran Mazumdar-Shaw (Executive Chairperson) |
| Products | Biopharmaceuticals, APIs, generics |
| Revenue (FY 2022) | ₹ 7,091 crore (approx. $950 million) |
| Number of Employees | Over 12,000 |
| Market Cap (2022) | ₹ 37,718 crore (approx. $5 billion) |
| Key Markets | India, USA, Europe, Emerging Markets |
| Key Subsidiaries | Syngene International Ltd. |
| Website | Biocon Ltd. |
8. Glenmark Pharmaceuticals Ltd.
Glenmark Pharmaceuticals Ltd., established in 1977 and based in Mumbai, Maharashtra, India, is a global pharmaceutical company specializing in generics, formulations, and APIs. Glenn Saldanha serves as Chairman & MD. Glenmark Pharma operates extensively across India, USA, Europe, and Latin America. In FY 2022, the company reported revenues of approximately ₹ 10,008 crore ($1.3 billion) with over 17,000 employees globally. The company’s market capitalization stands at around ₹ 22,019 crore ($3 billion) as of 2022.
| Company Name | Glenmark Pharmaceuticals Ltd. |
|---|---|
| Founded | 1977 |
| Headquarters | Mumbai, Maharashtra, India |
| Key People | Glenn Saldanha (Chairman & MD) |
| Products | Pharmaceuticals, generics, APIs |
| Revenue (FY 2022) | ₹ 10,008 crore (approx. $1.3 billion) |
| Number of Employees | Over 17,000 |
| Market Cap (2022) | ₹ 22,019 crore (approx. $3 billion) |
| Key Markets | India, USA, Europe, Latin America |
| Key Subsidiaries | Glenmark Life Sciences Ltd., Glenmark Generics Ltd. |
| Website | Glenmark Pharmaceuticals Ltd. |
9. Divi’s Laboratories Ltd.
Divi’s Laboratories Ltd., founded in 1990 and headquartered in Hyderabad, Telangana, India, specializes in manufacturing active pharmaceutical ingredients (APIs). Murali K. Divi serves as Chairman & MD. Divi’s Labs caters primarily to markets in the USA, Europe, Japan, and South Korea. In FY 2022, the company reported revenues of approximately ₹ 8,524 crore ($1.1 billion) with over 13,000 employees globally. Divi’s Labs has a significant market capitalization of approximately ₹ 1,17,726 crore ($15.8 billion) as of 2022.
| Company Name | Divi’s Laboratories Ltd. |
|---|---|
| Founded | 1990 |
| Headquarters | Hyderabad, Telangana, India |
| Key People | Murali K. Divi (Chairman & MD) |
| Products | Active pharmaceutical ingredients (APIs) |
| Revenue (FY 2022) | ₹ 8,524 crore (approx. $1.1 billion) |
| Number of Employees | Over 13,000 |
| Market Cap (2022) | ₹ 1,17,726 crore (approx. $15.8 billion) |
| Key Markets | USA, Europe, Japan, South Korea |
| Key Subsidiaries | Divi’s Laboratories USA Inc. |
| Website | Divi’s Laboratories Ltd. |
10. Wockhardt Ltd.
Wockhardt Ltd., founded in 1960 and based in Mumbai, Maharashtra, India, is a pharmaceutical and biotechnology company. Habil Khorakiwala serves as the Founder & Chairman. Wockhardt operates in key markets such as India, USA, UK, and Emerging Markets. In FY 2022, the company reported revenues of approximately ₹ 4,594 crore ($615 million) with over 6,000 employees globally. The company’s market capitalization stands at around ₹ 5,615 crore ($752 million) as of 2022.
| Company Name | Wockhardt Ltd. |
|---|---|
| Founded | 1960 |
| Headquarters | Mumbai, Maharashtra, India |
| Key People | Habil Khorakiwala (Founder & Chairman) |
| Products | Pharmaceuticals, biotechnology |
| Revenue (FY 2022) | ₹ 4,594 crore (approx. $615 million) |
| Number of Employees | Over 6,000 |
| Market Cap (2022) | ₹ 5,615 crore (approx. $752 million) |
| Key Markets | India, USA, UK, Emerging Markets |
| Key Subsidiaries | CP Pharmaceuticals Ltd., Wockhardt Bio AG |
| Website | Wockhardt Ltd. |
Overall, India’s top pharmaceutical companies, including Sun Pharma, Dr. Reddy’s, Cipla, Lupin, Aurobindo, Cadila, Torrent, Biocon, Glenmark, Divi’s, and Wockhardt, collectively showcase the country’s robust presence in global healthcare. These firms are leaders in generics, biotechnology, and APIs, with extensive operations across major markets like India, USA, and Europe. With substantial revenues, significant workforce sizes, and diverse product portfolios, they play pivotal roles in advancing healthcare accessibility and innovation worldwide. Their market capitalizations underscore their strategic importance and growth potential in the global pharmaceutical industry.
Also Read :
Top 10 IT Companies in India 2024
Top 10 semiconductor companies in India
Top 10 healthcare companies in India
Top 10 travel agencies in India
Top 10 Management consulting firms in India
Top 10 Multinational Companies (MNCs) in India
